Oncomedics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer (NCT05299840) | Oncomedics | 2023-06-07 |
Track Oncomedics automatically
Every clearance here is in the API, with alerts when new ones post.